Heart failure and stepdown units of the Sydell and Arnold Miller Family Heart & Vascular Institute have been testing electrocardiogram technology.
Meet Our New Heart Failure Section Head, Dr. Jerry Estep
The national PI of the ROADMAP trial shares his passion for VADs, current research projects that excite him and why he made a mid-career move to Cleveland Clinic.
What’s on the Horizon in Heart Failure Care and LVAD Technology?
Our experts share eight trends and developments that excite them most in mechanical circulatory support and beyond.
Enzyme Protects Heart Against Stress and Could Potentially Lead to New Heart Failure Treatments
Part of the paraoxynase family, PON2 is produced in the heart and appears to safeguard the organ from stressors.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
MitraClip Drives Down Deaths, HF Hospitalization in Secondary Mitral Regurgitation
The COAPT trial finds transcatheter mitral valve repair to be safe and highly effective in a setting with no good treatment options: symptomatic mitral regurgitation secondary to heart failure.
Research to Predict Pre- and Post-Transplant Survival in Heart Failure Lands $2.8M NIH Grant
The funding will support a three-pronged initiative using machine learning and other methods to identify factors behind survival disparities to improve survival and minimize organ wastage.
Prognostic Value of Right Atrial Pressure/Pulmonary Artery Wedge Pressure Ratio in Pulmonary Arterial Hypertension
These findings suggest that the RAP/PAWP ratio is a more specific marker of right heart dysfunction than RAP or any other traditional hemodynamic variable alone.
Nurses with CHFN Credentials Are Likely to Have Decision-Making in Heart Failure Management Consistent with Evidence-Based Practices
Cleveland Clinic’s ACNO of Nursing Research and Innovation led the first study to show a direct association between decision-making in clinical heart failure care, via clinical vignette scores, and CHFN status.
In LVAD Patients with Atrial Arrhythmias, Rhythm Control Offers Little Benefit
As the use of LVADs for destination therapy grows, a new study offers the first guidance on whether aggressive treatment for atrial arrhythmias makes a difference in this setting.
Pro-Collagen Pathway Regulated by MAS and CTGF May Promote Heart Failure
A study of human cardiac tissue shows that CTGF mediates the profibrotic effects of MAS in cardiac fibroblasts. The findings suggest a promising target for heart failure drug intervention.